Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · IEX Real-Time Price · USD
8.16
-0.27 (-3.20%)
At close: Jun 14, 2024, 4:00 PM
8.19
+0.03 (0.37%)
After-hours: Jun 14, 2024, 7:52 PM EDT

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had revenue of $1.90M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $715.00K. In the year 2023, Iovance Biotherapeutics had annual revenue of $1.19M.

Revenue (ttm)
$1.90M
Revenue Growth
n/a
P/S Ratio
1,199.28
Revenue / Employee
$3,418
Employees
557
Market Cap
2.28B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.19M--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Dec 31, 20070--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Integra LifeSciences Holdings 1.53B
ACADIA Pharmaceuticals 813.81M
10x Genomics 625.45M
NovoCure 525.66M
Certara 360.69M
ADMA Biologics 283.18M
RxSight 101.10M
Celldex Therapeutics 6.07M
Revenue Rankings